Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-19
2011-07-19
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S269000, C514S401000
Reexamination Certificate
active
07981899
ABSTRACT:
Disclosed are the use of compatible solutes for inhibiting the release of ceramides or for the prophylaxis and protection of human skin against premature skin aging and for the prophylaxis and protection of human skin against wrinkling.
REFERENCES:
patent: 2649397 (1950-05-01), Ballard
patent: 4346105 (1982-08-01), Sallmann et al.
patent: 4529587 (1985-07-01), Green et al.
patent: 4877805 (1989-10-01), Kligman et al.
patent: 5047409 (1991-09-01), DiSchiena et al.
patent: 5204099 (1993-04-01), Barbier et al.
patent: 5403845 (1995-04-01), Dunbar et al.
patent: 5476852 (1995-12-01), Cauwenbergh
patent: 5665366 (1997-09-01), Rawlings et al.
patent: 5738858 (1998-04-01), Burger
patent: 5780042 (1998-07-01), Gers-Barlag et al.
patent: 5789414 (1998-08-01), Lapidot et al.
patent: 5827508 (1998-10-01), Tanner et al.
patent: 5972718 (1999-10-01), Moghaddam et al.
patent: 6001838 (1999-12-01), Stockhammer et al.
patent: 6057282 (2000-05-01), Desai et al.
patent: 6060071 (2000-05-01), Motitschke et al.
patent: 6130254 (2000-10-01), Fisher et al.
patent: 6153176 (2000-11-01), Kaleta et al.
patent: 6267973 (2001-07-01), Motitschke et al.
patent: 6403112 (2002-06-01), Motitschke et al.
patent: 6551917 (2003-04-01), Cobbley et al.
patent: 6602514 (2003-08-01), Bunger et al.
patent: 6638543 (2003-10-01), Kang et al.
patent: 2002/0106337 (2002-08-01), Deckers et al.
patent: 2003/0114358 (2003-06-01), Galinski et al.
patent: 2003/0157040 (2003-08-01), Bunger et al.
patent: 2003/0190292 (2003-10-01), Bunger et al.
patent: 2003/0198609 (2003-10-01), Bunger et al.
patent: 2003/0199446 (2003-10-01), Bunger et al.
patent: 2004/0043940 (2004-03-01), Bunger et al.
patent: 2004/0047828 (2004-03-01), Bunger et al.
patent: 2 132 079 (1973-01-01), None
patent: 2 154 948 (1973-05-01), None
patent: 2614723 (1977-10-01), None
patent: 2746650 (1979-04-01), None
patent: 4244580 (1994-07-01), None
patent: 4342560 (1995-06-01), None
patent: 199 33 466 (2000-01-01), None
patent: 19933460 (2000-01-01), None
patent: 19933461 (2000-01-01), None
patent: 19933463 (2000-01-01), None
patent: 19933464 (2000-01-01), None
patent: 198 34 818 (2000-02-01), None
patent: 199 11 775 (2000-02-01), None
patent: 19834816 (2000-02-01), None
patent: 10006578 (2001-08-01), None
patent: 100 14 632 (2001-09-01), None
patent: 0 888 542 (1983-09-01), None
patent: 0 275 719 (1988-07-01), None
patent: 0 553 884 (1993-08-01), None
patent: 647469 (1995-04-01), None
patent: 0 671 161 (1995-09-01), None
patent: 0915167 (1999-05-01), None
patent: 1 125 583 (2001-08-01), None
patent: 1513659 (1978-06-01), None
patent: 2114886 (1983-09-01), None
patent: 02104577 (1990-04-01), None
patent: 3086867 (1991-11-01), None
patent: 3031265 (1991-12-01), None
patent: 9143167 (1997-06-01), None
patent: WO 94 04128 (1994-03-01), None
patent: WO 94/15923 (1994-07-01), None
patent: WO 96 17590 (1996-06-01), None
patent: WO 98 13020 (1998-04-01), None
patent: WO 0007558 (2000-02-01), None
patent: WO 0007560 (2000-02-01), None
patent: WO 00 76528 (2000-12-01), None
patent: WO 0158446 (2001-08-01), None
patent: WO 01 76572 (2001-10-01), None
patent: WO 0172263 (2001-10-01), None
patent: WO 0207522 (2002-01-01), None
patent: WO 03 007892 (2003-01-01), None
Mohammad, Taj, “Laser-induced In Vitro Isomerization of Urocanic Acid in UVA Region and the Origin of Excited Triplet State,” Tetrahedron Letters, vol. 43, pp. 8897-8900 (2002).
Beyer N et al: “Ectoin—A Innovative, Multi-Functional Active Substance for the Cosmetic Industry” SOFW-Journal Seifen, Oele Fette, Wachse, Verlag Fur Chemische Industrie, H. Ziolkowsky K.G. Augsburg, DE Bd. 126, Nr. 12, Dec. 2000, pp. 26,28-29.
Eisvogel M.: “Sun Protection With Anti-Ageing Merck Puts Ectoin to Work” Cossma, Nr. 4, 2001, pp. 32-33.
U.S. Appl. No. 08/355,275, Motitschke.
U.S. Appl. No. 08/746,253, Motitschke.
U.S. Appl. No. 09/744,766, Bunger et al.
U.S. Appl. No. 09/744,767, Bunger et al.
Galinski et al., “1,4,5,6-Tetrahydro-2-methyl-4-pyrimidinecarboxylic Acid,”Eur. J. Biochem.149:135-39 (1985).
Idson, B., “Dry Skin Moisturizing and Emolliency,”Cosmetics&Toiletries107:69-78 (1992).
Severin et al., “The Predominant Role of Recently Discovered Tetrahydropyrimidines for the Osmoadaptation of Halophilic Eubacteria,”Journal of General Microbiology138:1629-38 (1992).
Sauer T. et al., “Ectoine—Biotechnische produktion und moegliche anwendungsbereiche,” Git Fachzeitschrift Fuer Das Laboratorium, vol. 39, No. 10, pp. 892-896, 1995.
Buenger J., “Neue wirkstoffklasse schuetzt und pflegt die haut. ectoine stabilisieren biopolymerstrukturen,” Parfumerie und Kosmetik, vol. 79, No. 11, pp. 32-35, 1998.
Beyer N. et al., “Ectoin—a innovative multi-functional active substance for the cosmetic industry,” SOFW Journal, vol. 126, No. 12, pp. 26, 28-29, 2000.
Krezel, I., “Antitumor activity of new derivatives of 1,3-diazaheterocycles,” Pharmazie, vol. 53, No. 9, pp. 614-617, 1998.
Adams J.L. et al., “cis-4-Carboxy-6-(mercaptomethyl)-3,4,5,6-tetrahydropyrimidin-2(1H)-one, a potent inhibitor of mammalian dihydroorotase,” J.Med.Chem., vol. 31, No. 7, pp. 1355-1359, 1988.
RonaCare Ectoin—The Cell Protection Factor, Merck KGaA.
Galinski at al., “The Kosmotropic (Structure-Forming) Effect of Compensatory Solutes”, Comp. Biochem, Physiol. vol. 117A, No. 3, pp. 357-365, 1997.
Chemical Abstracts 132:170870, “Cosmetic compositions containing plant extracts having moisture-retaining effects”, Doi et al. (Feb. 22, 2000).
Chemical Abstracts 129:179959, “Betaine-containing toothpaste relieves subjective symptoms of drymouth”, Sondering et al. (1998).
Bünger Joachim
Krutmann Jean
Henley, III Raymond J
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
LandOfFree
Use of compatible solutes for inhibiting the release of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of compatible solutes for inhibiting the release of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of compatible solutes for inhibiting the release of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2738748